Our Team
Marvin Collin - President & Co-founder
Marvin Collin - President & Co-founder
Marvin has over 30 years of International Licensing, Business Development and Financial acumen. He has been recognized as a top performer in his capacities to provide financial and business consulting excellence to his clients in the High-Tech and Medical-BioTech. His research expertise in cytokines, stem cells and inflammatory biomarkers
Marvin has over 30 years of International Licensing, Business Development and Financial acumen. He has been recognized as a top performer in his capacities to provide financial and business consulting excellence to his clients in the High-Tech and Medical-BioTech. His research expertise in cytokines, stem cells and inflammatory biomarkers has been applied to numerous IRB clinical validation studies and the development of a screening methodology for early detection of CDA (cognitive decline, dementia and Alzheimer’s.)
Rami Cohen - CEO & Co - founder
Marvin Collin - President & Co-founder
Seasoned innovator and business developer, 20+ years of venture building, consultancy, several turn- arounds. Specialized in Health-Care decision support. In the early smart-phone days launched and raised funding for ClassifEye, a mobile security company. During the past decade, Rami turned 3 companies, one of which was acquired by one of
Seasoned innovator and business developer, 20+ years of venture building, consultancy, several turn- arounds. Specialized in Health-Care decision support. In the early smart-phone days launched and raised funding for ClassifEye, a mobile security company. During the past decade, Rami turned 3 companies, one of which was acquired by one of the leading SW development firms in Israel. During the last 3 years he has specialized in Data driven solutions for dementia management.
Dr. Raphael Nir - Chief Science Officer & Co-Founder
Dr. Raphael Nir - Chief Science Officer & Co-Founder
30 years of experience commercializing recombinant cytokines and pre-clinical contract research services. Dr. Nir is the Co-Founder of two preclinical Contract Research Organizations: SBH Sciences and Woodland Biosciences, four biotech companies: Karyopharm Therapeutics (Nasdaq: KPTI), Galectin Sciences, VuJa De Sciences, and Alma BioTherapeutics.
About Ascento CDA
Marko Lukic, MD, Phd, Chief Medical Director
An esteemed Ophthalmologist focusing on retina and uveitis. He is a consultant ophthalmologist at Moorfields Eye Hospital NHS Foundation Trust, contributing significantly to its medical retina digital imaging clinics. He has completed two fellowships at Moorfields Eye Hospital. Dr. Lukic's proactive role as an investigator in over 15 clinical trials further highlights his strong drive toward scientific discovery and medical advancements.
Judy Xiao-ke Gao, M.D. - Medical Advisor
Clinical Assistant Professor in Neurology at Weill Cornell Medical College. Dr.Gao is a top New York neurologist who
specializes in dynamic treatment of
neurological diseases, neuro-rehabilitation,
and physical therapy.
John L. Brooks, III, Executive Consultant & Strategic Advisor
John L. Brooks III is the Managing Director of Healthcare Capital LLC, which advises early-stage life sciences companies. Mr. Brooks is on the board of a number of public and private for-profit companies and not-for-profit organizations.
Mr. Brooks is the former President & Chief Executive Officer and Chairman of the Joslin Diabetes Center, a Boston based diabetes research, clinical care, and education organization.
Mr. Brooks is a well-known life sciences executive. He has co-founded eight life sciences companies. He was a co-founder of Prism Venture Partners, a $1.25B venture capital firm. He is also the co-founder of Insulet (PODD).
A native of Massachusetts, he holds an M.S. in Business Administration and a B.B.A. cum laude from the University of Massachusetts at Amherst and he is a Certified Public Accountant.
Ron Aaron - Chief Software Architect
Highly experienced software developer, who specializes in highly secured databases and mobile applications. Innovated "8th" cross platform development environment. previously worked at Tradigo, Hyperlink and ClassifEye.
David Cohen – Data Analysis Consultant
M.Sc Candidate in Computational Biology, Hebrew University, Israel. Proven scientific achievements in MRI analysis, leading to breakthrough in the field of brain tumors.
Matt Ayotte - Director of Strategic Accounts
Matt brings over 20 years of business development success to Ascento-CDA. As the Tampa Bay President and State Vice President, he quadrupled the membership of Florida’s oldest trade organization, the Florida Motion Picture & Television Association, working with Celebrities and Hollywood elite. After COVID hit, he took his development skills to an AI Tax Software company, specializing with International Taxes. His expertise led to significant creation of new business.